Hanmi Pharmaceutical Senior Vice President Choi In-young, head of the R&D center, speaks to Korean media outlets at a press ...

Korea’s largest pharmaceutical company, Hanmi Pharmaceutical, is testing a radio frequency identification system at five of its wholesalers, as well as at five retailer locations throughout the nation ...

Aptose Biosciences Inc. ("Aptose" or the "Company") (TSX: APS; OTC: APTOF), a clinical-stage precision oncology company ...

SEOUL, South Korea, April 2, 2025 /PRNewswire/ -- Hanmi Pharmaceutical's combination therapy for Obstructive Prostatic Growth (OPG) caused by Benign Prostatic Hyperplasia (BPH) and Erectile ...

Hanmi continues to work in close partnership with McKesson Automation, the regional distributor for JVM, to ensure a successful market entry. Hanmi Pharmaceutical CEO Park Jae-hyun said: "Moving ...

In response, Hanmi Pharmaceutical Group emphasized, 'The four-member coalition, including Shin, Chairman, and Radifangs, has a strong commitment to new drug development, which is the DNA and core ...

Hanmi Pharmaceuticals entered into an exclusive license, agreement with Janssen Pharmaceuticals for the development and commercialization of oxyntomodulin-based therapies including Hanmi's ...

SEOUL, South Korea, June 29, 2021 /PRNewswire/ -- Hanmi Pharmaceutical (hereinafter Hanmi) recently announced that its new, long-acting diabetes biologic drug, efpeglenatide, was shown to ...

View the latest Hanmi Pharmaceutical Co. Ltd. (128940) stock price, news, historical charts, analyst ratings and financial information from WSJ.

SEOUL, South Korea, Nov. 24, 2024 /PRNewswire/ -- The latest progress in the clinical trial of BH3120, an innovative immunotherapy jointly developed by Hanmi Pharmaceutical and Beijing Hanmi ...

Hanmi Pharmaceutical has consolidated its position as one of the leading drug makers in Korea, standing as the country's top pharmaceutical firm by market cap. However, growing risks from canceled ...

Hanmi Pharmaceutical announced that it has completed the launch of Aditams in Mexico under the export agreement signed in October 2020 with the Mexican pharmaceutical company 'Laboratorios Silanes'.